Skip to main content
GameRevenueData

Developer

BloodRain Publishing Games: Revenue & Sales Estimates

Revenue estimates for the 10 Steam games developed by BloodRain Publishing, ranked by estimated net revenue. Available estimated lifetime net (USD): $3.1K.

Catalog Est. Lifetime Net (USD)

$3.1K

Estimates for 8 of 10 tracked games

Tracked games

10

Top Earner

Prison Wars

$612

Coverage: 10 tracked titles; 8 with net estimates; 2 without. 0 have dedicated profiles. Missing estimates are excluded from the aggregate, not treated as known zero revenue.

Role: Developer. These are lifetime estimates for games credited to BloodRain Publishing; they are not company earnings, profit, or contractual receipts. Credits may omit co-development or historical publishing arrangements. Developer and publisher identities are not merged by matching names.

Recorded release dates: 2023-01-06–2023-04-23 (may include announced dates).

Largest title accounts for 19.6% of available estimated net revenue. Coverage gaps can change this share.

Showing 1–10 of the top 10 displayed entries, from 10 tracked titles. Figures include only available estimates. Search the full catalog .

Rows 1–10 · Page 1 of 1

# Game Est. lifetime net (USD) Positive reviews (raw) Release
1 Prison Wars $612 66%Mixed (29) Jan 6, 2023
2 INVASION $583 70%Positive (27) Feb 10, 2023
3 UNRESTRAINED $507 54%Mixed (24) Jan 13, 2023
4 The Last Hike $401 68%Mixed (19) Feb 17, 2023
5 Taste of War $302 86%Positive (14) Jan 20, 2023
6 GHOST HUNTER $259 25%Negative (12) Mar 21, 2023
7 CATACOMBS: The Beginning $253 67%Mixed (12) Jan 27, 2023
8 THE CURE $211 50%Mixed (10) Mar 23, 2023
9 Gold Rush 60%Mixed (5) Apr 23, 2023
10 Crazy Prisoner 0%Negative (2) Apr 11, 2023

Get real-time dashboards, historical trends, and AI-powered analysis

Explore on PlayRev(opens in new tab)

Revenue and sales estimates are based on the Boxleiter method using publicly available data including Steam review counts, pricing history, and statistical modeling. Actual revenue may differ significantly. These figures are provided for informational purposes only and should not be used for financial decisions. Read the full methodology.